Endometrial changes during ulipristal acetate use: A systematic review
- 1 July 2017
- journal article
- review article
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 214, 56-64
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- A prospective, open-label, multicenter study to assess the pharmacodynamics and safety of repeated use of 30 mg ulipristal acetateContraception, 2016
- A randomized study on pharmacodynamic effects of vaginal rings delivering the progesterone receptor modulator ulipristal acetate: research for a novel estrogen-free, method of contraceptionContraception, 2014
- Long-term treatment of uterine fibroids with ulipristal acetate☆Fertility and Sterility, 2014
- Emergency contraception — mechanisms of actionContraception, 2013
- Effects of a novel estrogen-free, progesterone receptor modulator contraceptive vaginal ring on inhibition of ovulation, bleeding patterns and endometrium in normal womenContraception, 2012
- Ulipristal Acetate versus Placebo for Fibroid Treatment before SurgeryNew England Journal of Medicine, 2012
- Ulipristal Acetate versus Leuprolide Acetate for Uterine FibroidsNew England Journal of Medicine, 2012
- Endometrial effects of a single early luteal dose of the selective progesterone receptor modulator CDB-2914Fertility and Sterility, 2010
- CDB-2914 for Uterine Leiomyomata TreatmentObstetrics & Gynecology, 2008
- Antiprogestins: Mechanism of Action and ContraceptiveAnnual Review of Pharmacology and Toxicology, 1996